Impact of chiglitazar on glycemic control in type 2 diabetic patients with metabolic syndrome and insulin resistance: A pooled data analysis from two phase III trials.
Zhiqiang NingGuoqiang AiBo ChenHe YaoHaixiang CaoDesi PanXianping LuPublished in: Journal of diabetes (2023)
Chiglitazar shows promising efficacy for glycemic control in patients with T2DM associated with MetS or IR. Further prospective trials are required to validate these findings.
Keyphrases
- glycemic control
- phase iii
- insulin resistance
- data analysis
- metabolic syndrome
- type diabetes
- open label
- blood glucose
- clinical trial
- adipose tissue
- high fat diet
- double blind
- skeletal muscle
- polycystic ovary syndrome
- high fat diet induced
- phase ii
- weight loss
- uric acid
- cardiovascular disease
- cardiovascular risk factors